| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/07/2003 | US20030147907 Retroviral vectors |
| 08/07/2003 | US20030147873 Cell culture prodcut for treating a behavioral or psychological disorders and brian disorders, brain transplant; stem cells |
| 08/07/2003 | US20030147856 Proteins |
| 08/07/2003 | CA2474467A1 Novel microorganism, its product and utilization thereof |
| 08/07/2003 | CA2474458A1 Method for detecting microorganisms |
| 08/07/2003 | CA2474339A1 Multiple virus replicon culture systems |
| 08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
| 08/06/2003 | EP1333035A2 Growth differentiation factor-8 |
| 08/06/2003 | EP1332222A2 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 08/06/2003 | EP1105051A4 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 08/06/2003 | EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
| 08/06/2003 | EP0833943B1 Method for identifying secretory genes in helicobacter pylori |
| 08/06/2003 | EP0728018B1 New enzymes and prodrugs for ADEPT |
| 08/06/2003 | CN1434869A Root-specific promoter |
| 08/06/2003 | CN1434865A Regulation effect of conjugated frame transport protein ABC1 |
| 08/06/2003 | CN1434861A Bacterial isolates of genus kiebsiella, and isomaltulose synthase gene isolated therefrom |
| 08/06/2003 | CN1434716A Anti-adhesive agent in relation to pathogenic flora of skin |
| 08/06/2003 | CN1117160C Process for the preparation of recombinant proteins in E coli by high cell density fermentation |
| 08/06/2003 | CN1117155C Novel compounds |
| 08/06/2003 | CN1117153C Thermophilic fungal expression system |
| 08/06/2003 | CN1117151C Riboflavin synthesis in fungi |
| 08/06/2003 | CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic |
| 08/06/2003 | CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections |
| 08/05/2003 | US6602984 Human elastase IV |
| 08/05/2003 | US6602697 Process for purifying human papillomavirus virus-like particles |
| 08/05/2003 | US6602691 Process for the production of mannitol by immobilized micro-organisms |
| 08/05/2003 | US6602690 Process for production of dihomo-γ-linolenic acid and lipid containing same |
| 08/05/2003 | US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent |
| 08/05/2003 | US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage |
| 08/05/2003 | US6602681 Reacting enzyme, of given amino acid sequence, produced by a recombinant DNA technique from Xenopus laevis |
| 08/05/2003 | US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions |
| 07/31/2003 | WO2003062439A1 Production of biodegradable thermoplastic materials from organic wastes |
| 07/31/2003 | WO2003062242A1 Biocidal compounds and their preparation |
| 07/31/2003 | WO2003062173A2 Alanine 2,3- aminomutase |
| 07/31/2003 | WO2003029484A3 Antimicrobial methods and materials |
| 07/31/2003 | US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica) |
| 07/31/2003 | US20030143739 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143715 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203 |
| 07/31/2003 | US20030143711 Hydrolyses organophosphate insecticides including malathion; bioremediation |
| 07/31/2003 | US20030143710 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides |
| 07/31/2003 | US20030143700 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity |
| 07/31/2003 | US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 07/31/2003 | US20030143680 Bacterial cells lacking deformylase and/or transformylase |
| 07/31/2003 | US20030143677 Activated rec-D-hydantoinases |
| 07/31/2003 | US20030143567 An expression vector containing a promoter operably linked to a nucleic acid that encodes a prokaryotic enzyme having both epimerase/ reductase activity catalyzes conversion of GDP-4-keto-6-deoxymannose to GDP-fucose |
| 07/31/2003 | US20030143530 Method for the detection of influenza a/b viruses |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143281 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | CA2473716A1 Alanine 2,3- aminomutase |
| 07/31/2003 | CA2471749A1 Biocidal compounds and their preparation |
| 07/30/2003 | EP1331270A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331009A1 Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 07/30/2003 | EP1330553A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 07/30/2003 | EP1330534A1 Method for obtaining 12-hydroxystearic acid |
| 07/30/2003 | EP1330513A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 07/30/2003 | EP1000078B1 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
| 07/30/2003 | EP0941349B1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | EP0730652B1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter |
| 07/30/2003 | EP0584206B1 Genetic control of acetylation of xanthan based polysaccharide polymers |
| 07/30/2003 | EP0545958B2 A process for hydrolyzing hemicellulose by enzymes produced by trichoderma reesei |
| 07/30/2003 | CN1433474A Regulaed antigen delivery system (RADS) involving bacteria |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433465A Method for preservation of viruses and mycorplasma |
| 07/30/2003 | CN1116304C Organic compound |
| 07/29/2003 | US6600029 Expression cassette for use as tools in the transfer of preferential nucleotide sequences into cells |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599930 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599734 Culturing cells or tissues; obtain cells, incubate with nutrient broth, propagte cells |
| 07/29/2003 | US6599730 Subtilisin for use in cleaning hard surfaces |
| 07/29/2003 | US6599722 Method for producing ascorbic acid intermediates |
| 07/29/2003 | US6599721 Chemical intermediates; hydrolysis using hydrolases |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599504 Strain of bacteria of the species Lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2122044C Hiv immunotherapeutics |
| 07/29/2003 | CA2097931C Salmonella vaccines |
| 07/29/2003 | CA2082802C Method for expressing polypeptides in cyanobacteria |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2067136C Growth hormone antagonists |
| 07/29/2003 | CA2053586C Defined culture medium for cho cells |
| 07/29/2003 | CA2017157C Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | US20030140376 Optimized t-dna transfer and vectors therefor |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139581 Protocadherin materials and methods |
| 07/24/2003 | US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 07/24/2003 | US20030138956 Improving transfer of plasmids/nucleotide sequences into escherichia |
| 07/24/2003 | US20030138937 Genetically engineered escherichia with reduced DNA complement for use as expression vector in efficient production of important cell products such as riboflavin, lysine and glutamic acid; increased homologous recombination |